Hua Qiong Shen

Hua Qiong Shen

Chief Executive Officer at
Neushen Therapeutics, Inc.
63 year
Health Technology
Consumer Services
Commercial Services

Profile

Currently, Hua Qiong Shen is Chief Executive Officer & Director at I-Mab. In the past Dr. Shen held the position of Senior Medical Director at Pfizer Inc. Medical Director of Wyeth Research and Senior Director & Head-Clinical Development at Pfizer (China) Research & Development Co., Ltd. (both are subsidiaries of Pfizer Inc.) and Chief Medical Officer & Vice President at Jiangsu Hengrui Pharmaceuticals Co., Ltd. Dr. Shen received a doctorate from Southeast University, a graduate degree from West China University of Medical Sciences and a doctorate from The Indiana University School of Medicine.

Hua Qiong Shen active positions

CompaniesPositionStart
Chief Executive Officer -
Director/Board Member 2026-01-15

Former positions of Hua Qiong Shen

CompaniesPositionEnd
NOVABRIDGE BIOSCIENCES Chief Executive Officer 2021-12-30
Corporate Officer/Principal 2017-08-31
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD Chief Tech/Sci/R&D Officer 2015-07-31
Pfizer (China) Research & Development Co. Ltd.
Director/Board Member 2013-04-30
PFIZER INC. Chief Tech/Sci/R&D Officer 2011-07-31
See the detail of Hua Qiong Shen's experience

Training of Hua Qiong Shen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Pfizer (China) Research & Development Co. Ltd.

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Hua Qiong Shen